1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 24,000 | 25,050 | 09.11. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| BASTIDE LE CONFORT MEDICAL Aktie jetzt für 0€ handeln | |||||
| 28.10. | BASTIDE: 2025-2026 financial calendar | 750 | Actusnews Wire | Caissargues, October 28, 2025
Events
Dates*
2025-2026 Q1 Revenue
Thursday November 13, 2025
2025-2026 H1 Revenue
Thursday February 12, 2026
2025-2026 H1 Results
Wednesday... ► Artikel lesen | |
| 22.10. | BASTIDE: 2024-2025 annual results in line with targets // 2025-26 outlook: Revenue of over EUR 510 million and recurring operating margin around 9%, Leverage of less than 3x and decrease in financial expenses | 595 | Actusnews Wire | Caissargues, October 22, 2025 - Groupe Bastide, a leading European provider of home healthcare services, has announced its 2024-2025 annual results at June 30, 2025. The 2024-2025 annual consolidated... ► Artikel lesen | |
| 24.09. | BASTIDE: Groupe Bastide completes the sale of Baywater Healthcare to Sapio Group | 589 | Actusnews Wire | Caissargues, September 24, 2025
In line with the timetable set out in its 30 June 2025 communication announcing the agreement to sell Baywater Healthcare, a leading player in the UK respiratory... ► Artikel lesen | |
| 04.09. | BASTIDE: 2024-2025 revenue target met // 2024-2025 revenue from continuing operations: EUR 491 million, up 8% ( EUR 561 million, excluding impact of disposals) | 414 | Actusnews Wire | Caissargues, September 4, 2025
Groupe Bastide has published its annual revenue for 2024-2025. In accordance with IFRS 5, reported revenue relates exclusively to continuing operations, and no... ► Artikel lesen | |
| 23.07. | La Bastide: A Taste Of Provence, One Hour From New York City | 2 | Forbes | ||
| 30.06. | BASTIDE: Bastide Groupe Sells Baywater Healthcare To Sapio Group | 561 | Actusnews Wire | Crewe, United Kingdom & Monza, Italy - 30th June 2025
Bastide le Confort Medical SA (hereinafter "Groupe Bastide") today announced that it has agreed to the sale of its subsidiary Baywater Healthcare... ► Artikel lesen | |
| 09.06. | BASTIDE: Disposal of CICADUM and MEDSOFT | 490 | Actusnews Wire | Caissargues, June 9, 2025
Bastide Groupe announced today the disposal of its French subsidiaries, Cicadum, 51%-owned, (signing subject to financing condition precedent) and Medsoft, 100%-owned... ► Artikel lesen | |
| 05.06. | BASTIDE: Disposal of DORGE and DYNA MEDICAL in Belgium | 460 | Actusnews Wire | Caissargues, June 5, 2025
Bastide Groupe announced today the disposal of its Belgian subsidiaries, Dorge Medic, which specializes in the sale and rental of medical equipment and products for... ► Artikel lesen | |
| 04.06. | BASTIDE: Respiratory care therapy: Baywater wins London region tender and consolidates its leading position in the UK | 413 | Actusnews Wire | Caissargues, June 4, 2025
After being chosen one year ago by the National Health Service (NHS) to be the exclusive operator for respiratory care (oxygen therapy) in the East of England region... ► Artikel lesen | |
| 15.05. | BASTIDE: Continued strong organic growth in Q3 2024-2025 at +7.7%: Home healthcare services up 10.4% and recovery of Homecare activities confirmed / 2024-2025 targets confirmed | 438 | Actusnews Wire | Caissargues, May 15, 2025
In € millions
2023-2024
published
2023-2024*
Adjusted
2024-2025
published
Change
First-quarter revenue
127.9
122.7
133.8
+9.1%
Second-quarter... ► Artikel lesen | |
| 19.03. | BASTIDE: 2024-2025 half-year results / Recurring operating margin at 9.1%, up 80 bps / Operating FCF positive at EUR 9.4 million / Improvement in financial leverage / upward revision of recurring operating margin target to 9.1% | 559 | Actusnews Wire | Caissargues, March 19, 2025 - Groupe Bastide, a leading European provider of home healthcare services, published its 2024-2025 half-year results on December 31, 2024. Groupe Bastide's 2024-2025... ► Artikel lesen | |
| 13.02. | BASTIDE: Organic growth of 8.4% in first-half 2024 2025: Home healthcare services up 10.2% and Return to growth in the Homecare business / 2024-2025 targets confirmed | 429 | Actusnews Wire | Caissargues, February 13, 2025
In € millions
2023-2024
published
2023-2024*
Adjusted
2024-2025
published
Change
First-quarter revenue
127.9
122.7
133.8
+9.1%
Second-quarter... ► Artikel lesen | |
| 08.01. | BASTIDE obtains an extended license to operate in Canada in the Respiratory Care segment / Sale of French stomatherapy subsidiary CICA PLUS | 379 | Actusnews Wire | Caissargues, January 8, 2025 - Groupe Bastide, one of Europe's leading players in home healthcare services, announces its newly extended license to operate in the field of respiratory care in British... ► Artikel lesen | |
| 14.11.24 | BASTIDE: Highly dynamic organic growth in Q1 2024-25 at 9.0%: 10.9% growth in home healthcare services and rebound in the homecare business, up 6.0% / Disposal of Swiss commercial business finalized and 2024-2025 targets confirmed | 437 | Actusnews Wire | Caissargues, November 14, 2024 - Groupe Bastide, a leading European provider of home healthcare services, has published its revenue for first-quarter 2024-2025, ending September 30, 2024.
In... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ANSELL | 20,400 | 0,00 % | ANSELL LIMITED: Update - Notification of buy-back - ANN | ||
| AMBEA | 11,580 | -0,52 % | Ambea AB: Ambea's interim report July - September 2025 | Stronger Nordic growth to meet society's care needs
CEO comments:
During the third quarter, we are accelerating growth and creating value by meeting more people's needs for quality care, while continuing... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,290 | -2,26 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers mit einem Kursziel von 61,30 Euro auf "Overweight" belassen. Analyst David Adlington stellte seine Schätzungen... ► Artikel lesen | |
| FRESENIUS | 47,640 | -1,26 % | AKTIE IM FOKUS 2: FMC fallen - Erwartung möglicher Platzierung durch Fresenius | (Neu: Weitere Details) FRANKFURT (dpa-AFX Broker) - Die Aktien von Fresenius Medical Care (FMC) sind am Dienstag trotz einer überraschend positiven Geschäftsentwicklung im dritten Quartal unter Druck... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,400 | -1,52 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| GERRESHEIMER | 24,020 | -4,38 % | PAUKENSCHLAG bei Gerresheimer! KAUFCHANCE bei TKMS und Kobo Resources! | Gold- und Rüstungsaktien haben in der vergangenen Woche ihre Verschnaufpause fortgesetzt. Dies bietet Chancen. Bei TKMS kauft ein Insider und Analysten sehen 25 % Kurspotenzial. Zudem sehen sie weiteres... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 33,140 | +1,72 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 42,460 | +1,68 % | Carl Zeiss Meditec-Aktie sorgt für Spannung - steht am Montag ein Richtungswechsel bevor?!! | ||
| PROGYNY | 22,370 | +24,21 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| UNITEDHEALTH | 280,55 | +0,14 % | UNITEDHEALTH GROUP INC steht vor einer explosiven Bewegung | ||
| OTTOBOCK | 68,25 | +0,37 % | Ottobock-Aktie im Rampenlicht - Marktbeobachter warnen vor plötzlicher Trendwende!!! | ||
| AIRSCULPT TECHNOLOGIES | 6,130 | -41,84 % | Airsculpt Technologies, Inc.: AirSculpt Technologies Reports Third Quarter Fiscal 2025 Results | MIAMI BEACH, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 31,930 | +2,01 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HIMS & HERS HEALTH | 35,540 | +0,17 % | Hims and Hers übertrifft Umsatzprognosen dank Wachstum bei Telemedizin und GLP-1-Angebot | Der US-Telemedizinanbieter Hims and Hers Health hat im dritten Quartal die Umsatzschätzungen der Analysten übertroffen. Das Unternehmen profitierte von einem Anstieg der Abonnentenzahlen und dem Ausbau... ► Artikel lesen | |
| CLEARPOINT NEURO | 15,810 | -13,27 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces Agreement to Acquire IRRAS | Acquisition Will Further Expand the Potential of ClearPoint Neuro's Drug Delivery Portfolio While Immediately Adding New Indications and Commercial Scale Across a $0.5 Billion Market for the Treatment... ► Artikel lesen |
BASTIDE LE CONFORT MEDICAL SA gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 24,000 Euro und damit -1,23 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BASTIDE LE CONFORT MEDICAL SA finden Sie auf Wallstreet Online.